Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Medisana AG Adjusts FY 2013 Outlook


Thursday, 14 Nov 2013 07:51am EST 

Medisana AG announced that following the end of the third quarter and the preparation of preliminary figures, the Management Board is no longer assuming that the Company will return to operating profitability in its current financial year, despite a slight increase in sales revenue and improved results. This is attributable to delays of sales revenues to subsequent quarters and lower demand in important product groups due to unfavorable weather conditions. Although the current fourth quarter is traditionally the Company's strongest quarter in terms of sales revenue and earnings, the Management Board anticipates that the operating result for the full 2013 financial year will continue to comprise a loss, although reflecting an improvement on the previous year's operating result. 

Company Quote

2.488
-0.035 -1.39%
28 Nov 2014